Sun Pharma Advanced Research Company Share Price
199.96-2.58 (-1.27%)
+36.19% past 1 Year
Sun Pharma Advanced Research Company Limited (SPARC) is a clinical stage bio-pharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery. The
Corporate filings & documents
Announcements
Filing of Application for Reclassification with Stock Exchanges
3 weeks agoFiling of Application for Reclassification with Stock Exchanges
3 weeks agoNewspaper Advertisement for Publication of Financials
3 weeks agoNewspaper Advertisement for Publication of Financials
3 weeks agoOutcome of 21st Annual General Meeting of Sun Pharma Advanced Research Company Limited held on August 10 2026
3 weeks agoOutcome of 21st Annual General Meeting of Sun Pharma Advanced Research Company Limited held on August 10 2026
3 weeks agoMonitoring Agency Report for the Quarter ended June 30 2026
3 weeks agoMonitoring Agency Report for the Quarter ended June 30 2026
3 weeks agoFinancial Results
3 weeks agoFinancial Results
3 weeks agoOutcome of the Board Meeting
3 weeks agoOutcome of the Board Meeting
3 weeks agoSun Pharma Advanced Research Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve unaudited standalone and consolidated financial results for the quarter ended June 30 2026
1 month agoSun Pharma Advanced Research Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve unaudited standalone and consolidated financial results for the quarter ended June 30 2026
1 month agoIntimation for Receipt of Request for Reclassification of Shareholder Category
1 month agoIntimation for Receipt of Request for Reclassification of Shareholder Category
1 month agoNewspaper Advertisement of 21st Annual General Meeting of Company and related information
1 month agoNewspaper Advertisement of 21st Annual General Meeting of Company and related information
1 month agoBusiness Responsibility and Sustainability Report for FY 26
1 month agoBusiness Responsibility and Sustainability Report for FY 26
1 month agoNotice of 21st Annual General Meeting along with the Annual Report for FY 26
1 month agoNotice of 21st Annual General Meeting along with the Annual Report for FY 26
1 month agoAnnual Report 2025-26 and the Notice of 21st Annual General Meeting
1 month agoAnnual Report 2025-26 and the Notice of 21st Annual General Meeting
1 month agoIntimation for change in Director
1 month agoIntimation for change in Director
1 month agoNewspaper Advertisement- 21st Annual General Meeting of the Company
1 month agoNewspaper Advertisement- 21st Annual General Meeting of the Company
1 month ago21st Annual General Meeting of the Company
1 month ago21st Annual General Meeting of the Company
1 month agoCompliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018
2 months agoCompliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018
2 months agoIntimation regarding Change in Senior Management Team of the Company
2 months agoIntimation regarding Change in Senior Management Team of the Company
2 months agoTermination of License Agreement with CMS Bridging DMCC
2 months agoTermination of License Agreement with CMS Bridging DMCC
2 months agoIntimation regarding Closure of Trading Window
2 months agoIntimation regarding Closure of Trading Window
2 months agoStatutory Auditors Certificate in terms of Regulation 169(5) of SEBI ICDRA Regualations 2018
3 months agoStatutory Auditors Certificate in terms of Regulation 169(5) of SEBI ICDRA Regualations 2018
3 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shanghvi Finance Pvt Ltd & PACs
3 months agoNewspaper Advertisement for Publication of Financials
3 months agoUpdate on PDP-716 NDA
3 months agoUpdate on PDP-716 NDA
3 months agoAllotment of 3 85 10 000 warrants pursuant to Preferential Issue
3 months agoAllotment of 3 85 10 000 warrants pursuant to Preferential Issue
3 months agoAudited Financial Results
3 months agoAudited Financial Results
3 months agoSun Pharma Advanced Research Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the Quarter and Financial Year ended March 31 2026
3 months agoSun Pharma Advanced Research Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the Quarter and Financial Year ended March 31 2026
3 months agoAnnual reports
Concalls & investor presentations
Nov 2024
ConcallPresentation
Nov 2021
ConcallPresentation
Corporate Actions
Date
Type
Details
2016-03-16
Rights
5:116;245.0 (Rights ratio;Offer price)
2012-08-23
Rights
1:7;67.0 (Rights ratio;Offer price)
Company details
Registered office
Plot No.5 & 6/1, Savli G. I. D. C. Estate Savli - Vadodara Highway Manjusar Vadodara Gujarat PIN: 391775 Tel No: 0265- 2330815 Fax No: 0265- 2354897 Email: [email protected] Internet: www.sparc.life
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Kajal Damania, Company Secretary & Compliance Officer
Robert J Spiegel, Non Executive Independent Director
Venkateswarlu Jasti, Non Executive Independent Director
Rekha Warriar, Non Executive Independent Director
Vidhi Shanghvi, Promoter & Non-Executive Director
Dilip S Shanghvi, Chairman
Details
BSE 532872
NSE SPARC
ISIN INE232I01014